Skip to content

Brain Electrophysiological Patterns in Obesity

ERP Study of Brain Electrophysiological Patterns in Obesity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00842569
Enrollment
69
Registered
2009-02-12
Start date
2008-01-31
Completion date
Unknown
Last updated
2009-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

obesity, cognitive process, reward, P300, ERP, Event-related potential during oddball paradigm, brain electrophysiological patterns, externalizing factor

Brief summary

There is growing evidence of behavioural and neurobiological overlaps between obesity and drug abuse. Reduction of the amplitude of P300, a component of event-related potentials (ERP) elicited by an oddball paradigm, is an electrophysiological characteristic and a marker of vulnerability in substance abuse. We want to determine whether obesity is associated with such electrophysiological features during an auditory oddball paradigm. We postulate that obesity could be associated with electrophysiological abnormalities that could be viewed as a possible vulnerability marker for food addiction.

Interventions

None listed

Sponsors

Centre de Recherche en Nutrition Humaine Rhone-Alpe
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* The inclusion criteria for the study are men and women aged 20-60 years, BMI 18.5-24.9 kg/m2 for control subjects and BMI\>30 kg/m2 for obese subjects, stable body weight over the previous 3 months, report of sedentary or moderate physical activity

Exclusion criteria

* The

Design outcomes

Primary

MeasureTime frame
Evaluation of amplitudes and latencies of the P300 complex of Event Related Potential during an oddball paradigm, in normal-weighted and obese subjects

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026